These are results from market research which was aimed at collecting data on how the product and its features are perceived among users and healthcare professionals.
In total 389 users and 95 healthcare professionals responded. Some users had more than 30 years of experience, while others had only just begun self-catheterization. Average age of participants was 55 years (varying from 9-89). Countries included were Sweden, Norway, Denmark, UK, the Netherlands, France, Germany and Switzerland.
The three main reasons for catheterization were SCI (para-/tetraplegia), MS and different prostate diagnosis. 17 % of the users had slightly reduced hand function and 5 % stated that their hand function was considerably reduced. 41 % used a wheelchair and 97 % of the users catheterized themselves.
It’s foldable into a convenient pocket size, making it easy to bring and handle in a discreet manner. 79% rated this feature 4 or 5 out of 5.
The convenient peel-open label makes it easy to open and access the catheter. 88% rated this feature 4 or 5 out of 5.
Not touching the catheter tube minimizes the risk of contamination, and the Insertion Grip also allows better control during the catherization. 71% rated this feature 4 or 5 out of 5.
LoFric Origo market study
After trying LoFric® Origo™, the users and the healthcare professionals (HCP's) have had their say.
LoFric® is the registered trademark of Wellspect HealthCare.
Product availability and/or product speciﬁcation may differ between markets, please contact your local representative for more information.
©2021 Wellspect HealthCare, a Dentsply Sirona Company. All rights reserved.